Accelerating delivery of radiopharmaceutical trials
Radiopharmaceutical trials are gaining traction across oncology and other therapeutic areas—but challenges remain in delivery, access, and scalability. In this expert-led webinar, leaders in clinical research, regulatory strategy, operational execution, and patient advocacy explore how to de-risk and accelerate these programs through integrated planning and patient-focused design.
Hear directly from experts who have helped sponsors navigate the complexities of radiopharmaceutical development—from aligning nuclear medicine and oncology teams to designing inclusive trials and enabling access beyond academic hubs. Also featured is an oncology patient who participated in a radiopharmaceutical clinical trial, and he shares his journey and perspective on what drives patient engagement.
Related Insights
Webinar
Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)
Nov 12, 2024
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Report
New Medicines, Novel Insights: Advancing Precision Oncology
May 14, 2024
Blog
Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications
Feb 4, 2025
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Related Insights
Webinar
Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)
Nov 12, 2024
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Report
New Medicines, Novel Insights: Advancing Precision Oncology
May 14, 2024
Blog
Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications
Feb 4, 2025
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024